Challenges in the Integration of Omics and Non-Omics Data

Current predictive models often struggle to translate high-throughput biological data into effective clinical tools. While omics technologies have advanced rapidly, their standalone performance in public health settings remains limited. Clinical and epidemiological information frequently accounts for the majority of observed variation in health-related traits. This gap motivated researchers to explore the potential of combining these diverse data sources. Prior work has shown that integrating non-omics variables could significantly enhance the predictive power of existing algorithms. However, few studies have successfully achieved a comprehensive synthesis of these distinct data types. That uncertainty drove the need for a systematic evaluation of current integrative methodologies. No prior work had resolved the complexities associated with merging large-scale biological datasets with heterogeneous clinical records.

This review aims to evaluate current strategies for combining biological and clinical information in predictive modeling. The authors seek to address why existing algorithms frequently fail to reach clinical implementation standards. They investigate the specific challenges posed by the nature and heterogeneity of non-omics datasets. The study explores the difficulties of merging large-scale biological information with traditional epidemiological records. Researchers examine the impact of ascertainment bias on the relationship between these two distinct data types. The paper analyzes the presence of interactions and subphenotypes that complicate current integrative efforts. The authors intend to provide a comprehensive discussion of previous attempts at data synthesis. Finally, the work proposes new analytical frameworks to guide future efforts in this field.

The authors conducted a systematic review of existing literature focused on combining biological and clinical information. This review approach involved identifying studies that performed a real synthesis of these distinct data sources. The researchers categorized the selected papers based on their specific modeling frameworks. They evaluated how these studies handled the inherent heterogeneity of non-omics information. The team assessed the dimensionality of the clinical variables included in each model. They examined the prevalence of single-omics versus multi-omics data usage across the identified literature. The analysis focused on identifying common challenges such as ascertainment bias and model fairness. Finally, the authors synthesized these findings to propose improved analytical strategies for future research.

The literature review reveals that very few studies have successfully performed a real integration of biological and clinical datasets. Most identified papers focused exclusively on predicting cancer outcomes using these combined approaches. The findings show that the majority of reviewed studies incorporated only one type of omics data. Specifically, RNA expression data emerged as the most frequently used biological dataset in these models. All selected papers utilized non-omics data in a low-dimensionality fashion throughout their analysis. The review confirms that current algorithms often lack sufficient predictive ability for implementation in public health. The authors found that three distinct modeling methods—independent, conditional, and joint—dominate the current landscape. These results highlight a significant gap between existing methodologies and the requirements for robust clinical application.

The authors synthesize existing literature to highlight the current limitations in predictive modeling for clinical applications. They argue that successful integration requires addressing the inherent heterogeneity found in non-omics datasets. The review identifies three primary modeling frameworks currently employed for combining these disparate data sources. Researchers emphasize that independent, conditional, and joint approaches each offer unique advantages and drawbacks. The analysis suggests that future efforts must prioritize mitigating ascertainment bias to improve model fairness. Furthermore, the authors propose that accounting for subphenotypes is necessary for robust predictive performance. The synthesis implies that current reliance on single-omics datasets limits the broader utility of these models. Finally, the authors advocate for the development of novel analytical strategies to overcome existing technical barriers.